RichardHKimMD

Clinical Trials

• Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer Start of enrollment: 2011 Apr 07

  Completed

  Phase 2

• Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer Start of enrollment: 2011 Jun 01

  Completed

  Phase 1

• SOM 230 and Gemcitabine in Advanced Pancreatic Cancer Start of enrollment: 2011 Jun 01

  Completed

  Phase 1

• Phase I Trial of Combination of FOLFIRI and SOM 230 Start of enrollment: 2011 Sep 01

  Completed

  Phase 1

• SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) Start of enrollment: 2012 Dec 01

  Completed

  Phase 2

• Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer Start of enrollment: 2013 Apr 01

  Terminated

  Phase 2

• Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer Start of enrollment: 2014 Apr 01

  Recruiting

  Phase 3

• Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Start of enrollment: 2014 Feb 01

  Completed

  Phase 2

• Single Agent Regorafenib in Refractory Advanced Biliary Cancers Start of enrollment: 2014 Jun 05

  Completed

  Phase 2

• Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer Start of enrollment: 2014 May 22

  Completed

  Phase 1

• BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer Start of enrollment: 2014 Oct 30

  Completed

  Phase 1

• Join now to see all